Tag: Dr Mal Eutick
Phebra partners with University of Wollongong to develop drug for leukemia, pancreatic cancer
Australian pharmaceutical firm Phebra and the University of Wollongong (UOW) have entered into a six-year collaboration agreement to carry out research and development (R&D) and trials of patented and targeted arsenic compounds for the treatment of acute myeloid leukemias and pancreatic cancer.
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
